La Roche Posay Laboratoire Dermatologique Effaclar Pore Refining Acne Treatment

La Roche Posay Laboratoire Dermatologique Effaclar Pore Refining Acne Treatment is an FDA drug label for the active ingredient SALICYLIC ACID manufactured by L'Oreal USA Products Inc administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231213.

Generic: SALICYLIC ACID

Manufacturer: L'Oreal USA Products Inc

Product Type: HUMAN OTC DRUG

Route: TOPICAL

Dosage Form:

NDC: 49967-529

Application: M006

Effective: 20231213

Active Ingredients: Active ingredient Salicylic acid 1.5%

Indications & Usage

Uses clears acne blemishes penetrates pores to control acne blemishes helps prevent new acne blemishes from forming

Dosage & Administration

Directions clean the skin thoroughly before applying this product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day children under 12 years of age: ask a doctor

Contraindications

Not available.

Warnings

Warnings For external use only

Adverse Reactions

Not available.

More from same ingredient

ACNE AND LINE CORRECTING SERUM

CLINIQUE LABORATORIES LLC

ACNE CLEANSING

CLINIQUE LABORATORIES LLC

Acne Advanced Clarifying Hydrator

Eminence Organic Skin Care Ltd.

Acne Advanced Clarifying Masque

Eminence Organic Skin Care Ltd.

Acne Advanced Cleansing

Eminence Organic Skin Care Ltd.